Corticosteroid prophylaxis for patients receiving intravascular contrast agents: a survey of current practice in Australia and New Zealand.
A survey was made of the use of corticosteroid prophylaxis in patients receiving intravascular contrast media. The replies of 807 respondents were available for analysis and they indicate that such a strategy is common for 'high-risk' patients (62.4%), but very few respondents use corticosteroid prophylaxis for all patients (0.74%).
Bensusan
D
D
Department of Diagnostic Radiology, Prince Henry Hospital, Sydney, New South Wales, Australia.
Stevenson
J D
JD
Palmer
F J
FJ
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D001315:Australia; D003287:Contrast Media / Q000009:adverse effects*; D004363:Drug Utilization / Q000706:statistics & numerical data*; D006801:Humans; D009520:New Zealand; D009994:Osmolar Concentration; D010818:Practice Patterns, Physicians'; D011292:Premedication / Q000706:statistics & numerical data*; D012307:Risk Factors
D000305:Adrenal Cortex Hormones; D003287:Contrast Media